• OPEN AN ACCOUNT
Indian Indices
Nifty
25,453.40 -88.40
(-0.35%)
Sensex
83,239.47 -170.22
( -0.20%)
Bank Nifty
56,999.20 -460.25
( -0.80%)
Nifty IT
38,879.10 45.95
( 0.12%)
Global Indices
Nasdaq
44,498.76 -17.19
(-0.04%)
Dow Jones
6,247.07 28.06
(0.45%)
Hang Seng
39,705.85 -56.63
(-0.14%)
Nikkei 225
8,774.69 -10.64
(-0.12%)
Forex
USD-INR
85.59 -0.04
(-0.04%)
EUR-INR
100.92 0.38
(0.38%)
GBP-INR
117.62 0.20
(0.17%)
JPY-INR
0.60 0.00
(0.46%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
290.2218799
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
35.14
31840.72
EPS(TTM)
Face Value()
Div & Yield %
72.53
2
1.1
 

Mahindra & Mahindra June sales jump 14%
Jul 01,2025

Mahindra & Mahindra  announced that its overall auto sales for the month of June 2025 stood at 78,969 vehicles, a growth of 14%, including exports.

In the Utility Vehicles segment, Mahindra sold 47,306 vehicles in the domestic market, a growth of 18% and overall, 48,329 vehicles, including exports. The domestic sales for Commercial Vehicles stood at 20,575.

According to Nalinikanth Gollagunta, CEO, Automotive Division, M&M, “In June, we achieved SUV sales of 47,306 units, a growth of 18%, and total vehicle sales of 78,969 units, a 14% growth compared to the same month last year. The quarter ended on a very positive note for us, marking the highest quarter ever for SUVs.”